Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 7 Oct, 01:30 am
Investment firm Needham significantly raised its price target for Vaxcyte (NASDAQ: PCVX) , citing positive clinical trial data for its experimental vaccine. Vaxcyte's VAX-31 pneumococcal vaccine met all primary endpoints in its Phase 3 OPUS-1 trial, demonstrating noninferiority a
RBC Capital maintained an "Outperform" rating for IG Group (OTC: IGGHY) despite recent challenges in its financial performance. The company cut its 2026 guidance, anticipating a 14% drop in third-quarter revenue, which led to a significant 27% fall in its share price. Panmure Lib
Investigational drug Rina-S demonstrated a 45.9% confirmed response rate in Phase 1/2 trials for platinum-resistant ovarian cancer, with a median response duration of 12.1 months . Despite some serious adverse events, the positive clinical trial results support further Phase 3 st
BNP Paribas Exane raised NVIDIA (NASDAQ: NVDA) ’s price target to $345 from $285, reflecting strong demand for its AI chips. NVIDIA shares are outperforming the broader S&P 500 in 2026, though they have recently lagged the wider semiconductor industry group. The stock t
Raymond James has increased its price target for SBA Communications to $271.00 , implying significant upside from its current share price. Growth is fueled by rising mobile data demand, network expansion by wireless carriers , and consistent recurring lease payments . Key risks i
Schneider Electric (EPA: SU) is set to acquire PTC Inc. (NASDAQ: PTC) for $205.00 per share in cash, aiming to create one of the largest industrial software portfolios. The proposed acquisition price of $205.00 per share represents a significant premium over PTC's recent trading
SPX Technologies (NYSE: SPXC) recently traded near its 52-week low, even as several analyst targets remain well above the current stock price. Oppenheimer lowered its price target to $270 from $280 while maintaining an Outperform rating. Analyst sentiment remains generally positi
PBF Energy (NYSE: PBF) shares have gained sharply over the past year, trading near record levels after stronger refining margins and improved quarterly results. The company reduced net term debt by more than $1.40 billion in Q2 2026, refinanced notes, and maintained a solid cash
J D Wetherspoon (OTC: JDWPY) reported an impressive 8.6% rise in like-for-like sales during the initial nine weeks of its new financial year, driven partly by favorable weather conditions. Despite a 5.2% increase in annual revenue to £2.24 billion , profit before tax and separate
Oppenheimer reaffirmed its Outperform rating for Enphase Energy (NASDAQ: ENPH) but lowered its price target from $56.00 to $55.00 . Enphase Energy specializes in solar microinverters, home batteries, and energy management products. ENPH shares have recently declined 9.6%, underpe
UBS raised its price target for Ball Corp. (NYSE: BALL) to $66.00 from $65.00 while maintaining a Neutral rating. With Ball Corp. trading at $56.37, the revised target suggests about 17.1% potential upside. Steady packaging demand, growth in South America, dividends, and possible
The WisdomTree Japan Hedged Equity Fund (AMEX: DXJ) is scheduled for a 1-for-3 reverse stock split on October 9, 2026. A stock split changes the number of shares an investor owns but does not alter the total value of their investment. Japanese equities, including the Nikkei 225 ,
Fractyl Health (NASDAQ:GUTS) executed a 12-for-1 reverse stock split on October 5, 2026, to consolidate shares. This reverse stock split followed a significant 74.86% decline in Fractyl Health's stock price over two trading days. The company is currently facing a federal securiti
Significant Earnings Miss: Taylor Devices (NASDAQ: TAYD) reported fiscal Q1 2027 earnings of $0.14 per share, substantially below the estimated $0.92 , with revenue of $7.30 million also falling short of the $13.10 million estimate. Sales Decline and Profit Pressure: Sales for th
BMO Capital's $212.00 price target suggests a 25% upside for nVent Electric (NYSE: NVT) from its $169.56 trading price. The Maverick Power acquisition and strong organic growth are driven by increasing data center demand , expanding nVent Electric's market presence. nVent Electri
BMO Capital initiated coverage on Vertiv (NYSE: VRT) with an Outperform rating and a $329.00 price target , indicating substantial upside potential. The company's growth is significantly fueled by increasing demand for AI data centers , driving strong stock performance and revenu
Goldman Sachs has initiated coverage on LVMH (OTCMKTS: LVMUY) with a "Buy" rating, highlighting its position in the luxury market. The broader luxury stocks sector faces an evolving investment outlook, with some analysts noting a potential shift in valuations. Analyst sentiment f
Bernstein analyst Lee Hambright has lowered the price target for Boston Scientific (NYSE:BSX) to $54.00 from $60.00 . Boston Scientific shares are currently lagging the broader market and the Medical sector, with the stock closing at $42.60 on October 2, 2026. The medical device
Headlines provided by Investing.com